These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16545646)

  • 21. Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies.
    Aktas MK; Kim DD; McNitt S; Huang DT; Rosero SZ; Hall BW; Zareba W; Daubert JP
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1501-8. PubMed ID: 19793373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between atrial fibrillation and sudden cardiac death: the relevance of heart failure.
    Reinier K; Marijon E; Uy-Evanado A; Teodorescu C; Narayanan K; Chugh H; Gunson K; Jui J; Chugh SS
    JACC Heart Fail; 2014 Jun; 2(3):221-7. PubMed ID: 24952687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction.
    La Vecchia L; Zanolla L; Varotto L; Bonanno C; Spadaro GL; Ometto R; Fontanelli A
    Am Heart J; 2001 Jul; 142(1):181-9. PubMed ID: 11431676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of short-term heart rate variability for prediction of sudden cardiac death after acute myocardial infarction.
    Kautzner J; St'ovícek P; Anger Z; Savlíková J; Malik M
    Acta Univ Palacki Olomuc Fac Med; 1998; 141():69-73. PubMed ID: 9684488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden cardiac death early after ST elevation myocardial infarction with and without severe left ventricular dysfunction.
    Chitnis N; Vooturi S; Hygriv Rao B
    Indian Heart J; 2014; 66(6):569-73. PubMed ID: 25634386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT.
    Franqui-Rivera H; Sotomonte JC
    P R Health Sci J; 2011 Jun; 30(2):78-83. PubMed ID: 21682151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry.
    Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H;
    Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
    J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
    Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
    Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
    Schoenenberger AW; Kobza R; Jamshidi P; Zuber M; Abbate A; Stuck AE; Pfisterer M; Erne P
    Am J Cardiol; 2009 Jul; 104(2):158-63. PubMed ID: 19576339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent implantation in patients with severe left ventricular systolic dysfunction.
    Briguori C; Aranzulla TC; Airoldi F; Cosgrave J; Tavano D; Michev I; Montorfano M; Carlino M; Castelli A; Sangiorgi MG; Colombo A
    Int J Cardiol; 2009 Jul; 135(3):376-84. PubMed ID: 18625527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
    J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sudden cardiac death in 14- to 35-year olds in Ireland from 2005 to 2007: a retrospective registry.
    Margey R; Roy A; Tobin S; O'Keane CJ; McGorrian C; Morris V; Jennings S; Galvin J
    Europace; 2011 Oct; 13(10):1411-8. PubMed ID: 21798877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of left ventricular systolic dysfunction on survival after renal transplantation.
    Siedlecki A; Foushee M; Curtis JJ; Gaston RS; Perry G; Iskandrian AE; de Mattos AM
    Transplantation; 2007 Dec; 84(12):1610-7. PubMed ID: 18165772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular diameter and risk stratification for sudden cardiac death.
    Narayanan K; Reinier K; Teodorescu C; Uy-Evanado A; Aleong R; Chugh H; Nichols GA; Gunson K; London B; Jui J; Chugh SS
    J Am Heart Assoc; 2014 Sep; 3(5):e001193. PubMed ID: 25227407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.